Full-Time

HR Business Partner

LGC Group

LGC Group

1,001-5,000 employees

Sells oligos, probes, primers, viral materials

No salary listed

Berlin, Germany

Hybrid

Hybrid role: 3 days on-site and 2 days remote per week.

Category
People & HR (1)
Required Skills
Excel/Numbers/Sheets
Requirements
  • Significant generalist Human Resources experience, with in-depth understanding across all Human Resources disciplines in the employee lifecycle; ideally professionally qualified
  • Ability to work both strategically and operationally: demonstrable evidence of designing and delivering strategic Human Resources initiatives; a track record in delivering quality Human Resources operation services
  • Extensive, in-depth experience in organisational design and development
  • Significant experience designing and managing complex change initiatives, including restructurings, culture change
  • Demonstrable in-depth experience in designing and delivering training and learning interventions
  • Commercial and financial understanding; good numeracy skills; excellent Excel and good all round IT skills; good understanding of artificial intelligence and its application in Human Resources
  • Excellent written and verbal communication skills; demonstrable ability to influence at all levels; good facilitation and presentation skills
  • Proactive self-starter with an energetic, can-do and engaging style
  • Results-orientated with a track record of delivering quality work and projects on time
  • Excellent employment law knowledge; significant experience advising on and handling employee relations matters and collaboration with Works Councils or similar bodies
  • Experience analysing and using Human Resources data to identify trends and people priorities
  • Experienced championing and delivering Diversity, Equity, Inclusion and Belonging initiatives
  • Good stakeholder management and coaching skills; ideally a certified coach
  • Proven ability to work in a matrix organization, including the ability to prioritise across geographies and local initiatives, as well as balance priorities
  • Focused on delivery, with a clear understanding of key performance indicators and indicators of success
Responsibilities
  • Partner with business unit leadership teams to develop and deliver the people strategy locally that will help drive and deliver organisational and team effectiveness and business objectives
  • Support and coach leaders and managers in designing and implementing effective organisational structures, enabling the creation of teams and a work environment that underpins high engagement and performance; ensure good people management practices are in place
  • Provide HR and project management expertise in supporting the development and implementation of organisational change, including reorganisations, cultural alignment etc
  • Develop and utilise appropriate people analytics to monitor effectiveness and inform business decisions; use data insights to evidence and recommend solutions to improve engagement, performance, and to manage and retain talent
  • Advise and manage employee relations matters; proactively apply learning from ER cases to develop people manager capability
  • Champion and drive Diversity, Equity, Inclusion and Belonging initiatives in the business units; support the business to build an inclusive culture across all aspects of the employee journey
  • Work collaboratively with the HR Centres of Excellence and HR Operations to ensure alignment of the wider people initiatives and operations within local HR practices; work closely with global and local HR Business Partner teams and play an active role in project work and the delivery of high-quality HR operational support
  • Lead and coordinate a comprehensive performance management approach across stakeholders, working closely with the Centers of Excellence
  • Assess, plan and manage LGC talent, with a focus on learning and engagement, using global tools to deliver local results; design and deliver training to upskill, develop the competence and capability of colleagues and people managers to enable engagement, improve performance, and support the delivery of people initiatives and business objectives

LGC Group provides life-sciences tools and services worldwide, including oligo components, probes, primers, recombinant viral materials, and proficiency-testing schemes for food safety. Its products support vaccine development, diagnostics, and therapies through mass spectrometry, immunoassays, and nucleic acid chemistry. It differentiates itself with a broad catalog of high-quality tools plus global proficiency-testing services and a wide customer base across diagnostics, healthcare, and pharma. Its goal is to improve healthcare outcomes and help create safer vaccines and treatments by delivering reliable tools and quality services.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

London, United Kingdom

Founded

1841

Simplify Jobs

Simplify's Take

What believers are saying

  • $100M Canada synthesis center opened September 9, 2025 boosts pharma capacity.
  • DiaMex acquisition on December 4, 2024 expands clinical diagnostics portfolio.
  • New Guildford labs strengthen UK measurement science leadership.

What critics are saying

  • New CEO Joydeep Goswami disrupts ChromaDex and DiaMex integrations.
  • Thermo Fisher undercuts LGC reference materials with cheaper solutions.
  • Canada center validation fails, causing 20-30% revenue shortfall.

What makes LGC Group unique

  • LGC leads in reference materials with ChromaDex acquisition on February 26, 2026.
  • LGC specializes in oligo components for vaccines against COVID-19 and Ebola.
  • LGC excels in proficiency testing for food safety and anti-doping via SSAS.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at LGC Group who can refer or advise you

Benefits

Hybrid Work Options

Remote Work Options

Company News

LGC Group
Feb 26th, 2026
LGC Group strengthens its reference material portfolio and North American reach with the acquisition of the ChromaDex Reference Standards business

LGC Group strengthens its reference material portfolio and North American reach with the acquisition of the ChromaDex Reference Standards business. The acquisition further enhances LGC's ability to support pharmaceutical, food, and testing laboratories with trusted reference materials that underpin safety, quality, and regulatory confidence. London, UK, 26 February 2026. LGC Group, a global leader in life sciences, diagnostics, and analytical solutions, today announced the acquisition of the ChromaDex Reference Standards portfolio from Niagen Bioscience (NASDAQ: NAGE). The acquisition expands LGC's reference materials offering and strengthens its commercial reach across North America. The acquisition brings an established portfolio of phytochemical reference materials for the dietary supplements industry into LGC, enabling direct engagement with a broad base of laboratory customers and strengthening LGC's ability to support pharmaceutical companies, testing laboratories, and food producers operating in regulated markets. Bruno Rossi, EVP & General Manager, LGC Standards, said: "The ChromaDex standards portfolio further enhances LGC's ability to support our pharmaceutical customers, testing laboratories, and food producers. Building on LGC's position as a world leader in reference materials and analytical standards, this acquisition expands our North American commercial reach and further supports customers in generating reliable data that safeguards product integrity and confidence across global supply chains." For over 25 years, the ChromaDex Reference Standards portfolio has been built on deep expertise in phytochemical characterisation and analytical verification. The portfolio includes over 3,000 phytochemical reference materials, spanning major classes such as alkaloids, flavonoids, terpenes, carotenoids, organic acids, stilbenoids, vitamins, and select botanicals and plant-based compounds. These materials are widely used to support ingredient verification, method development, authenticity testing, contamination detection, and routine quality control across complex global supply chains. Rob Fried, CEO of Niagen Bioscience, remarked, "This transaction reflects our disciplined focus on what we do best - advancing NAD+ science and delivering clinically proven, patented Niagen(R) solutions across consumer and clinical channels. Selling Reference Standards to LGC is a meaningful step in simplifying our business and ensuring we are allocating capital and talent toward the highest-impact opportunities for shareholders." The acquisition of the ChromaDex Reference Standards portfolio demonstrates LGC's commitment to providing trusted reference materials and measurement solutions that reinforce product safety, quality, and regulatory confidence, advancing its mission of Science for a Safer World. LGC is a global leader in life sciences, diagnostics, and analytical solutions. LGC Group work with partners around the world to address some of society's most important challenges, from diagnosing disease and enabling new treatments to supporting food security and protecting public health. Its science supports discovery, enables better health outcomes and helps safeguard the integrity of food, water, medicines and the environment. Every day, LGC Group provide the components, standards and services that laboratories, manufacturers and regulators rely on to make confident, evidence-based decisions. With operations in 14 countries and more than 180 years of scientific expertise, its work supports public health and sustainability at a global scale. From improving the accuracy of medical testing and verifying the safety of food products, to helping scientists develop the next generation of medicines, its solutions are trusted by customers in more than 170 countries. For further information please contact: Customer contact: Richard Pembrey Sales Director, LGC Standards +1 603 851 2834 Media contact: Magda Bartoszewicz Director Corporate Brand and Communications, LGC Group +44 7408 850 514

CHEManager
Sep 12th, 2025
LGC Opens $100 Million Pharma Synthesis Center in Canada

LGC Group has inaugurated a CAD$100 million (€61.5 million) Organic Chemistry Synthesis Centre of Excellence in Vaughan, canada, significantly expanding global capacity for advanced research chemicals to support the pharmaceutical and life sciences sectors.

Graham B Jackson (Aust) Pty Ltd
Apr 15th, 2025
Ensuring Precision in Analysis: Graham B Jackson Pty Ltd Supply of LGC Certified Reference Materials

Graham B Jackson Pty Ltd (GBJPL), an Australian leader in reference materials, partners with the globally renowned LGC Group to supply high-quality CRMs to laboratories across the country.

Health Technology Insights
Apr 4th, 2025
Laboratory Proficiency Testing Market to Reach $2.1 Billion by 2030

For example, LGC Group introduced a proficiency testing (PT) service in April 2020 that uses nucleic acid amplification testing to identify SARS-CoV-2 (COVID-19).

Investors in Healthcare
Jan 10th, 2025
UK: LGC appoints Joydeep Goswami as president and CEO

UK-based LGC, an international life sciences measurement and tools company, has appointed Joydeep Goswami as president and CEO, succeeding Euan O'Sullivan, who decided to step down from his role in early 2024 after fourteen years of service.